ClinicalTrials.gov
public full text
Public Domain
An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
28-Day double-blinded efficacy and safety trial of SPX-101 Inhalation Solution in adult subjects with cystic fibrosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis#915333
- Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease#1111758
- Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis#1059318
- Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis#865267
- The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis#1095695
Record · ID 844875
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive